Vaxart VXRT
OTC VXRT
$0.36 -0.02 (-5.26%)
At close: Nov 10, 2026 · 4:00 PM EST

Vaxart (VXRT) Construction in Progress (2021 - 2026)

Updated

Analysis

Vaxart (VXRT) Construction in Progress (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vaxart 87.73 Mn 22.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 335,000.00
Dec 31, 2025 158,000.00
Sep 30, 2025 11,000.00
Jun 30, 2025 17,000.00
Mar 31, 2025 86,000.00
Dec 31, 2024 160,000.00
Sep 30, 2024 141,000.00
Jun 30, 2024 191,000.00
Mar 31, 2024 226,000.00
Dec 31, 2023 24,000.00
Sep 30, 2023 27,000.00
Jun 30, 2023 676,000.00
Mar 31, 2023 476,000.00
Dec 31, 2022 3.98 Mn
Mar 31, 2022 2.18 Mn
Dec 31, 2021 1.31 Mn
Sep 30, 2021 1.58 Mn
Jun 30, 2021 2.58 Mn
Mar 31, 2021 519,000.00
API Access

Vaxart Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=VXRT&period=max&api_key=YOUR_API_KEY